DIA 2023: What is Biofourmis Currently Working on with CancerX?

Published on: 

In an interview at the 2023 DIA annual meeting with ACT editor, Andy Studna, Jaydev Thakkar, chief operating officer, Biofourmis, disucsses how Biofourmis is working with CancerX to address the financial burden cancer treatment can place on patients.